And Diagnostic Value of DCTN1, DCTN2, and DCTN4 in Colon Adenocarcinoma
Total Page:16
File Type:pdf, Size:1020Kb
Journal name: Cancer Management and Research Article Designation: Original Research Year: 2018 Volume: 10 Cancer Management and Research Dovepress Running head verso: Wang et al Running head recto: Prognostic and diagnostic value of dynactin in colon adenocarcinoma open access to scientific and medical research DOI: http://dx.doi.org/10.2147/CMAR.S183062 Open Access Full Text Article ORIGINAL RESEARCH Distinct prognostic value of dynactin subunit 4 (DCTN4) and diagnostic value of DCTN1, DCTN2, and DCTN4 in colon adenocarcinoma Shijun Wang1 Background: Colon adenocarcinoma (COAD) is ranked as the third most commonly diagnosed Qiaoqi Wang2 cancer in both women and men, and it is the most frequently occurring malignant tumor. Dynactin Xiqian Zhang3 is a protein compound based on multiple subunits, including dynactin 1–6 (DCTN1–6), in most Xiwen Liao4 categories of cytoplasmic dynein performance in eukaryotes. Nevertheless, correlations between Guixian Wang1 the DCTN family and the prognosis and diagnosis of COAD remain unidentified. Statistics for DCTN mRNA expression in patients with COAD were acquired from Long Yu5 Methods: The Cancer Genome Atlas. Kaplan–Meier analyses and a Cox regression model were applied Wei Zhang1 to determine overall survival, with computation of HRs and 95% CIs. Several online data 1 Quanbo Zhou portals were used to assess the biological process, and pathway examination was performed 1 Shengyun Hu using the Kyoto Encyclopedia of Genes and Genomes to predict the biological functionality 1 Weitang Yuan of DCTN genes. 1Department of Colorectal and Results: We found that high expression of DCTN4 was linked with satisfactory results for overall Anal Surgery, The First Affiliated survival (P=0.042, HR=0.650, 95% CI 0.429–0.985). The expression of DCTN1, DATN2, and Hospital of Zhengzhou University, Zhengzhou, Henan Province, China; DCTN4 was closely correlated with the frequency of colon tumors (P<0.001, area under the 2Department of Medical Cosmetology, curve [AUC]=0.8811, 95% CI 0.8311–0.9312; P<0.001, AUC=0.870, 96% CI 0.833–0.9071; The Second Affiliated Hospital of and P=0.0051, AUC=0.6317, 95% CI 0.5725–0.6908, respectively). In the enrichment exami- Guangxi Medical University, Nanning, Guangxi Province, China; 3Department nation, the level of gene expression was related to the cell cycle, cell apoptosis, and the cell of Radiotherapy, The First Affiliated metastasis pathway. Hospital of Zhengzhou University, The expression levels of DCTN1, DCTN2, and DCTN4 could allow differentia- Henan Province, China; 4Department Conclusion: of Hepatobiliary Surgery, The First tion between cancer-bearing tissues and paracancerous tissue. These genes can be applied as Affiliated Hospital of Guangxi Medical biomarkers to predict the prognosis and diagnosis of COAD. University, Nanning, Guangxi Province, China; 5Department of Hepatobiliary Keywords: dynactin, colon adenocarcinoma, diagnosis, prognosis, biomarker Surgery, The First Affiliated Hospital of Zhengzhou University, Henan Province, China Introduction Colon adenocarcinoma (COAD) is a type of colorectal cancer (CRC) and is the most frequently occurring malignant tumor. In USA, it is ranked as the third most frequently diagnosed tumor in both males and females.1 Moreover, in 2018, the number of new cases was predicted to be 97,220, and the predicted number of deaths was 50,630.2 Correspondence: Weitang Yuan; Shijun Wang The Surveillance, Epidemiology, and End Results Program (SEER) found that the Department of Colorectal and Anal 5-year survival rate is 64.5% (https://seer.cancer.gov). The risk factors involved in this Surgery, The First Affiliated Hospital disease are old age, male gender, increased level of fat consumption, alcohol, physical of Zhengzhou University, Zhengzhou 450002, Henan Province, China inactivity, smoking, red meat, obesity, and processed food.3,4 Treatment of CRC may Tel +86 371 6796 7141 include combinations of surgery, radiotherapy, chemotherapy, and targeted therapy.5 Email [email protected]; [email protected] Diagnostic methods include colonoscopy, which is referred to as the gold standard submit your manuscript | www.dovepress.com Cancer Management and Research 2018:10 5807–5824 5807 Dovepress © 2018 Wang et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work http://dx.doi.org/10.2147/CMAR.S183062 you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Wang et al Dovepress for diagnosis and can provide a highly accurate diagnosis the gene ontology (GO) functional examination and the and assess the location of the tumor5; capsule endoscopy; Kyoto Encyclopedia of Genes and Genomes (KEGG) path- computed tomography colonography; and biomarkers of way examination. The functional examination based on GO CRC such as Septin-9 (SEPT9).5–7 includes the molecular functionality (MF), biological process Dynactin is a multiple-subunit protein compound (BP), and cellular component (CC). involved in the activation of most forms of cytoplasmic A GO function analysis tool, Biological Networks Gene dynein in eukaryotes.8 Dynactin connects to cytoplasmic Ontology (BiNGO),16 was applied for predicting the func- dynein, dynein cargo adaptors, and microtubules.9 Six tionality of gene based on the results of correlation analysis. subunits of dynactin, DCTN1, DCTN2, DCTN3, DCTN4, A gene function prediction website, Gene Multiple Asso- DCTN5, and DCTN6, have been verified, and all the subunits ciation Network Integration Algorithm (GeneMANIA), was are encoded through their corresponding genes. Previous used to predict DCTN family members.17 The Search Tool research found that the DCTN family is linked with multiple for the Retrieval of Interacting Genes/Proteins (STRING) neurodegenerative diseases.10–12 Nevertheless, after biblio- database which offers a critical evaluation and combination graphic retrieval, it was found that only a few studies stated of protein–protein interactions,18 was employed for assess- the correlation between the DCTN family and the prognosis ing the functional and physical relationships of DCTN4 and and diagnosis of COAD. correlated genes, with a collective score >0.15 being taken In this research, we accessed a public database, The to indicate statistical significance. Cancer Genome Atlas (TCGA), to assess survival-related data and DCTN family expression in patients with COAD, Co-expression matrix of the DCTN family and examined the prognostic and diagnostic value of mRNA in COAD expression levels of individual DCTN genes. Several online Pearson correlation coefficient analysis was used to identify data portals were employed for analyzing the functionality correlations between DCTN family genes in COAD. Results and signaling pathways in a bid to predict the functionality with P<0.01 were considered to be statistically significant. of DCTN genes. Characteristics of gene expression levels Materials and methods We used the Metabolic gEne RApid Visualizer (MERAV) to Data preparation make boxplots of various expression levels of DCTN family Data including mRNA expression and clinical information members in primary colon cancer-bearing tissue and normal that may be linked with COAD, including gender, age, colon tissue.19 Vertical scatterplots were produced based and tumor stage, were extracted from TCGA data portal, on the DCTN gene expression. Furthermore, the high and accessed by the University of California Santa Cruz Xena low expression level groups of DCTN genes were identified (UCSC Xena: https://xena.ucsc.edu/, retrieved June 21, according to the median values of each gene. Patients with 2018). mRNA sequencing was used in 456 patients. The expression values greater than the median values of specific expression data, which include 480 cases of cancer and 42 DCTN genes were identified as the high expression group, non-cancer mRNA sequences, were used for performing and the remaining patients were identified as the low expres- expression-associated examinations. After the cases with sion group. missing medical data and 0-day survival time had been removed, a total of 438 cases were included in the survival Diagnostic prediction examination. Receiver operating characteristics (ROC) curves were drawn to identify the prognostic importance of the DCTN Functional analysis and mRNA co- family in TCGA data portal. Standardized values of expression of the DCTN family diagnosis with P<0.05 were considered to be statistically The relevant degrees of expression of the six DCTN genes significant. in multiple different tissues were created by GTEx Portal.13 The Database for Annotation, Visualization, and Integrated Survival analysis Discovery (DAVID, v.6.8)14,15 was employed to analyze the The log-rank test, together with Kaplan–Meier survival functional enrichment, which includes two terminologies, examination, was applied to calculate the P-value and overall 5808 submit your manuscript | www.dovepress.com Cancer Management and Research 2018:10 Dovepress Dovepress Prognostic and diagnostic value of dynactin in colon adenocarcinoma